Curis, Inc. filed a Post-Effective Amendment No. 1 to fourteen Form S-8 registration statements on November 13, 2026, reflecting that shares previously registered under its 2010 Stock Incentive Plan and inducement award grants will now be available for issuance under the company's newly approved …
Curis, Inc. filed a Post-Effective Amendment No. 1 to fourteen Form S-8 registration statements on November 13, 2026, reflecting that up to 173,744 previously registered shares of common stock will now be available for issuance under the company's 2026 Incentive Plan rather than the …
Curis, Inc. filed a Form S-3 registration statement with the SEC on November 13, 2026, covering the resale of up to 33,333,360 shares of common stock by selling stockholders who participated in an October 2026 private placement.
Boston Omaha Corporation filed a Form 8-K on November 13, 2026, disclosing the Board of Directors' November 11, 2026 decision to increase its share repurchase program from $30 million to $85 million, alongside the release of its third quarter 2026 financial results.
Everspin Technologies, Inc. filed a Form S-3 shelf registration statement with the SEC on November 13, 2026, seeking to register up to $100,000,000 in securities including common stock, preferred stock, debt securities, and warrants.
Hennessy Capital Investment Corp. VIII filed its quarterly report on Form 10-Q with the SEC on November 13, 2026, covering the period ended September 30, 2026, and reporting results following the completion of its Initial Public Offering earlier in the year.
Lifeloc Technologies, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, reporting a net loss of $84,931 for the third quarter, a narrowing from the $263,439 net loss recorded in the same quarter of the prior year.
OTG Acquisition Corp. I filed a Form 10-Q with the SEC on November 13, 2026, covering the quarterly period ended September 30, 2026, disclosing net income of $2,131,872 for the three months ended September 30, 2026.
Enveric Biosciences, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 13, 2026, disclosing a net loss of $2,549,354 for the third quarter and total assets of $6,371,370.
Irenic Acquisition Corp. filed its Form 10-Q for the quarter ended September 30, 2026, with the SEC on November 13, 2026, reporting financial results for the period from its March 4, 2026 inception through that date.